Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transcription factor
c-Jun
plays a key role in controlling epithelium cell proliferation, apoptosis and differentiation. However, molecular mechanism and biological functions of
c-Jun
in squamous differentiation and the progression of esophageal squamous cell carcinoma (ESCC) remain elusive. In this study, we found that
c-Jun
bound directly to the promoter region, and activated the transcription of differentiation-associated genes including cystatin A, involucrin and
SPRR3
in vivo. Ectopic expression of
c-Jun
enhanced
SPRR3
transactivation in KYSE450 cells. Conversely, TAM67, a dominant negative mutant of
c-Jun
, inhibited
SPRR3
transactivation.
c-Jun
increased expression of SPPR3 mainly via a PKC/JNK pathway in response to TPA in KYSE450 cells. Furthermore,
c-Jun
was remarkably reduced in esophageal cancer. Interestingly, cystatin A, involucrin and
SPRR3
were significantly downregulated as well, and associated with differentiation grade. Expression of
c-Jun
was correlated with the expression of these genes in normal epithelium and ESCC. Importantly, the expression of these genes was remarkably decreased during the malignant transformation from normal epithelium to low-grade intraepithelial neoplasia (LGIN) or high-grade intraepithelial neoplasia (HGIN). The expression of cystatin A and involucrin was significantly reduced from LGIN to HGIN. These results suggest
c-Jun
was involved in the regulation of differentiation-associated genes in ESCC. These genes might serve as the potential markers in distinguishing normal epithelium from esophageal squamous intraepithelial neoplasia.
...
PMID:Differentiation-associated genes regulated by c-Jun and decreased in the progression of esophageal squamous cell carcinoma. 2479 31